06.06.2024 13:00:10 - EQS-PVR: aap Implantate AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

===
EQS Voting Rights Announcement: aap Implantate AG
aap Implantate AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the
objective of Europe-wide distribution
2024-06-06 / 13:00 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
On June 5, 2024, we informed you pursuant to Section 33 (1) WpHG that the share of voting rights of Dr. Georg Haindl,
Germany, in aap Implantate AG, Lorenzweg 5, 12099 Berlin, entered in the commercial register of the Charlottenburg
Local Court under HRB 64083, exceeded the threshold of 10% on June 5, 2024. On this date, the total share of voting
rights amounted to 25.44% (corresponding to 2,793,570 voting rights).
Against this background, we inform you of the following pursuant to Section 43 WpHG para. 1:
1. Objectives of the acquisition of the voting rights (Section 43 para. 1 sentences 1 and 3 WpHG)
a) With the investment, the notifying party aims at a longer-term strategic commitment in aap Implantate AG. However,
it should be noted that this is a predominantly financial investment; there is no investment in the same industry and
economic interests are paramount.
b) The notifying party reserves the right to obtain further voting rights in the issuer within the next twelve months
by acquisition or otherwise should opportunities arise that are consistent with the objectives of the material
participation.
c) The notifying party intends to exert influence on the composition of administrative, management and supervisory
bodies. In doing so, the notifying party will enter into a close dialog with the corporate bodies of aap Implantate AG.
d) The notifying party does not intend to significantly change the capital structure with regard to the ratio of
equity and debt financing of aap Implantate AG.
2. Origin of the funds used for the acquisition of the voting rights (ยง 43 para. 1 sentence 4 WpHG) With regard to the
origin of the funds, the notifying party informs that the acquisition of the voting rights was financed 100% with own
funds.

2024-06-06 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press
Releases.
Archive at www.eqs-news.com  
Language:     English 
Company:      aap Implantate AG 

Lorenzweg 5
12099 Berlin
Germany
Internet: www.aap.de

End of News EQS News Service
===
1919789 2024-06-06 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1919789&application_name=news

END) Dow Jones Newswires

June 06, 2024 07:00 ET (11:00 GMT)
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
AAP IMPLANTATE AG O.N. A3H210 Xetra 1,210 02.07.24 17:36:26 ±0,000 ±0,00% 0,000 0,000 1,210 1,210

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH